VitalConnect

VitalConnect is a medical device company specializing in wearable biosensor technology for continuous patient monitoring. The company's flagship product, VitalPatch, is a single-use biosensor that monitors up to 11 vital signs including live ECG, enabling real-time remote patient monitoring both in hospital settings and at home.

The VitalConnect Solution combines the VitalPatch wearable device with telehealth-enabled software for data streaming and clinical monitoring. The platform supports various clinical applications including cardiac monitoring through VitalPatch RTM (a first-of-its-kind extended Holter technology), hospital-at-home programs, and COVID-19 patient monitoring. The system allows physicians to monitor patients remotely while minimizing caregiver exposure in infectious disease scenarios.

The company experienced significant growth acceleration in 2021 driven by increased telehealth adoption during the COVID-19 pandemic. VitalConnect initiated the TELESTAR-TAVR clinical study in 2020 to further validate its monitoring technology in specialized cardiac procedures.

VitalConnect should be considered by healthcare organizations seeking a comprehensive remote monitoring solution that combines FDA-cleared wearable technology with telehealth software. The company is particularly well-positioned for cardiac monitoring programs requiring extended wear time and continuous ECG data.

Organizations implementing hospital-at-home models or seeking to reduce in-person monitoring during infectious disease outbreaks will benefit from the platform's real-time data transmission and remote monitoring capabilities. The single-device, multi-parameter approach simplifies patient experience compared to multiple monitoring devices.

VitalConnect operates exclusively in the healthcare sector as a medical device manufacturer for remote patient monitoring. The company focuses specifically on cardiac care, hospital-at-home programs, and acute/post-acute monitoring scenarios. Their technology addresses HIPAA-compliant data transmission requirements and supports clinical workflows for cardiologists, hospitalists, and remote monitoring teams.

The platform demonstrated particular utility during COVID-19 for monitoring infected patients while minimizing healthcare worker exposure, and continues to support infectious disease monitoring protocols alongside standard cardiac and vital signs monitoring applications.

Hospital systems and health networks implementing remote patient monitoring programs, particularly cardiology departments requiring extended cardiac monitoring. Organizations developing hospital-at-home capabilities or post-discharge monitoring programs for high-risk patients. Clinical research organizations conducting studies requiring continuous vital signs data collection.